Landscapes / Companies
Oncotherapeutics not checked
FollowEvery new trial, moved date and filing, and a Monday email
Next date
None yet
Drugs
1
in active trials · 3 in all
Trials
3 active
9 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Ruxolitinibnot checked |
Kinase Inhibitor; janus kinase inhibitor |
Phase 1 | — | ||
| How it works | Blocks JAK enzymes that pass on immune signals | ||||
| Also tested for | Multiple Myeloma | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021